CNY:PA:PA-HSBC MSCI China UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 6.235

Change

0.00 (0.00)%

Market Cap

USD 0.57B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.16 (-0.34%)

USD 60.76B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-12.30 (-2.11%)

USD 13.44B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-8.52 (-2.05%)

USD 12.33B
WRD:PA HSBC MSCI World UCITS ETF

-0.60 (-1.62%)

USD 10.94B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-18.05 (-3.55%)

USD 8.92B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.16 (-0.06%)

USD 8.60B
WLD:PA Lyxor UCITS MSCI World D-EUR

-5.83 (-1.60%)

USD 7.71B
HHH:PA HSBC S&P 500 UCITS ETF

-1.19 (-2.02%)

USD 7.47B
LCWD:PA Multi Units Luxembourg - Lyxor..

-0.33 (-1.69%)

USD 6.81B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

-3.28 (-1.98%)

USD 5.39B

ETFs Containing CNY:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.24% 20% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.24% 20% F 33% F
Trailing 12 Months  
Capital Gain 27.53% 84% B 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.53% 84% B 86% B+
Trailing 5 Years  
Capital Gain -16.88% 11% F 34% F
Dividend Return 4.73% 10% F 14% F
Total Return -12.15% 12% F 33% F
Average Annual (5 Year Horizon)  
Capital Gain -7.60% 5% F 20% F
Dividend Return N/A 9% A- 11% F
Total Return N/A 7% C- 4% F
Risk Return Profile  
Volatility (Standard Deviation) N/A 6% D- 17% F
Risk Adjusted Return N/A 1% F 12% F
Market Capitalization 0.57B 68% D+ 71% C-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.